Amgen announces $1bn investment to establish new US drug manufacturing facility
Amgen has announced a $1bn investment to establish a second US drug substance manufacturing facility in North Carolina. The expansion builds on the company’s previously announced $550m commitment in Holly Springs, bringing its total planned investment in …